ChromoGenics receives order from Hemsö of approximately SEK 1.3 million with I-Window glass
ChromoGenics AB (publ) has signed an agreement with Hemsö to deliver I-Window glass to the school Vittra Södermalm in Stockholm for a retro-fit project where existing glass are replaced with energy-efficient I-Window glass.
The project is a repeat order for a retro-fit project of 241 sqm I-Window glass including construction work with planned delivery in the fourth quarter of 2018.
In connection with the completion of the first installation of 768 sqm I-Window glass earlier this year, Hemsö chooses to continue upgrading the school's windows where the tenant Vittra Södermalm runs the school activities.
"We are proud that Hemsö has chosen to invest in additional I-Window glass for the school Vittra Södermalm in Stockholm. ChromoGenics I-Window glass regulates heating and cooling transmission in buildings, which provides better indoor comfort. The order demonstrates the need for energy efficient and maintenance-free solar control solutions with maintained views and healthy daylight. Together we can create a pleasant indoor environment," says Jerker Lundgren, CEO of ChromoGenics.
Jerker Lundgren, CEO
Susanne Andersson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
This information constitutes such information that ChromoGenics AB (publ) is obligated to disclose in accordance with the EU Market Abuse Regulation. The information was submitted by the above-mentioned contact persons for publication on September 18, 2018, at 08:30 CET.
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
ChromoGenics offers dynamic glass with controllable heat- and light transmission. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight® also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. www.chromogenics.com